nafamostat has been researched along with methotrexate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, M; Murakawa, M; Niho, Y; Okamura, T; Otsuka, T; Shibuya, T | 1 |
| Hamaue, N; Hirafuji, M; Iizuka, K; Kikuchi, K; Machida, T; Minami, M | 1 |
| Hamaue, N; Hasebe, S; Hiraide, S; Iizuka, K; Kobayashi, N; Machida, T; Tamura, M; Tanno, C; Yamamoto, T | 1 |
3 other study(ies) available for nafamostat and methotrexate
| Article | Year |
|---|---|
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamidines; Cyclophosphamide; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; Male; Methotrexate; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protease Inhibitors; Vincristine | 1992 |
Effects of nafamostat mesilate on 5-hydroxytryptamine release from isolated ileal tissues induced by anti-cancer drugs in rats.
Topics: Animals; Benzamidines; Cisplatin; Disease Models, Animal; Guanidines; Ileum; Intestine, Small; Male; Methotrexate; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Serotonin | 2020 |
Low-dose nafamostat mesilate ameliorates tissue injury and inhibits 5-hydroxytryptamine synthesis in the rat intestine after methotrexate administration.
Topics: Animals; Guanidines; Intestines; Methotrexate; Mucositis; Rats; Serotonin | 2023 |